Frontier Capital Management CO LLC Global Blood Therapeutics, Inc. Transaction History

Frontier Capital Management CO LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 19, 2022	SELL	$24.9 - $40.26 $4.48 Million - $7.24 Million	-179,806 Closed	0 $0
Q3 2021 Oct 19, 2021	SELL	$25.48 - $37.34 $4.09 Million - $6 Million	-160,626 Reduced 47.18%	179,806 $4.58 Million
Q2 2021 Aug 09, 2021	SELL	$32.46 - $43.42 $17.7 Million - $23.7 Million	-545,868 Reduced 61.59%	340,432 $11.9 Million
Q1 2021 May 13, 2021	BUY	$38.94 - $50.85 $34.5 Million - $45.1 Million	886,300 New	886,300 $36.1 Million
Q3 2020 Nov 16, 2020	SELL	$52.76 - $74.49 $4.86 Million - $6.87 Million	-92,201 Closed	0 $0
Q2 2020 Jul 17, 2020	BUY	$48.73 - $81.82 $1.92 Million - $3.22 Million	39,342 Added 74.43%	92,201 $5.82 Million
Q1 2020 Apr 16, 2020	SELL	$41.72 - $87.2 $3.39 Million - $7.08 Million	-81,141 Reduced 60.55%	52,859 $2.7 Million
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $3.33 Million - $5.96 Million	72,816 Added 119.01%	134,000 $10.7 Million
Q3 2019 Nov 14, 2019	SELL	$45.35 - $57.91 $94,509 - $120,684	-2,084 Reduced 3.29%	61,184 $2.97 Million
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $3.33 Million - $4 Million	63,268 New	63,268 $3.33 Million
Q2 2018 Aug 03, 2018	SELL	$38.7 - $50.15 $7.43 Million - $9.62 Million	-191,890 Closed	0 $0
Q1 2018 Apr 30, 2018	BUY	$39.6 - $65.9 $7.6 Million - $12.6 Million	191,890 New	191,890 $9.27 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Frontier Capital Management CO LLC with notifications on news.